Stockreport

Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM [Yahoo! Finance]

Pfizer, Inc.  (PFE) 
Last pfizer, inc. earnings: 4/28 06:45 am Check Earnings Report
PDF February 27 positive results from the Phase 3 EV-304 clinical trial for PADCEVTM, a Nectin-4 directed antibody-drug conjugate, in combination with Keytruda®, a PD-1 inhi [Read more]